Question 1

What is MGAT2-congenital disorder of glycosylation?

Accepted Answer

MGAT2-congenital disorder of glycosylation is a very rare inherited condition affecting multiple systems, particularly impacting neurological development and facial features. Caused by loss-of-function mutations in the MGAT2 gene, it is characterized by distinctive facial dysmorphism and significant developmental challenges. It is inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the altered gene to be affected. Due to its exceedingly low prevalence, it affects fewer than 1 in 1,000,000 people.

Question 2

What are the symptoms of MGAT2-congenital disorder of glycosylation?

Accepted Answer

Individuals with MGAT2-congenital disorder of glycosylation typically present with a range of features that impact both physical appearance and cognitive function. The condition is marked by a characteristic facial appearance including large, posteriorly rotated ears, a convex nasal ridge, an open mouth, and crowded teeth. In addition, there is severe global developmental delay and profound intellectual disability, along with motor stereotypy, seizures, and failure to thrive. A bleeding tendency due to diminished platelet aggregation may also be observed. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes MGAT2-congenital disorder of glycosylation?

Accepted Answer

MGAT2-congenital disorder of glycosylation is caused by loss-of-function mutations in the MGAT2 gene, which plays a critical role in the N-linked glycosylation pathway. The proper functioning of this enzyme is essential for the formation of glycoproteins, and its disruption leads to the multi-system features observed in affected individuals. The condition follows an autosomal recessive inheritance pattern, meaning that both parents must carry a copy of the pathogenic variant. Families with shared ancestry may have an increased chance of both carrying this rare variant. Associated genes include MGAT2.

Question 4

How is MGAT2-congenital disorder of glycosylation inherited?

Accepted Answer

MGAT2-congenital disorder of glycosylation follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is MGAT2-congenital disorder of glycosylation?

Accepted Answer

MGAT2-congenital disorder of glycosylation is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is MGAT2-congenital disorder of glycosylation diagnosed?

Accepted Answer

Diagnosis of MGAT2-congenital disorder of glycosylation is confirmed through molecular genetic testing that identifies pathogenic variants in the MGAT2 gene. In addition, clinical evaluation including detailed assessment of the characteristic facial features, developmental history, and bleeding issues plays an important role. Since several of the observed features can be seen in other conditions, genetic testing is essential to establish the definitive diagnosis.

Question 7

Are there treatments for MGAT2-congenital disorder of glycosylation?

Accepted Answer

Currently, management of MGAT2-congenital disorder of glycosylation focuses on supportive care and symptom management. Treatment is tailored to the individual and involves a multidisciplinary approach, with regular surveillance to monitor for complications such as bleeding tendencies and neurological issues. In addition, genetic counseling is recommended to help families understand the condition and its inheritance, ensuring that patients discuss available management options with their healthcare team.

Question 8

What complications can arise from MGAT2-congenital disorder of glycosylation?

Accepted Answer

Complications from MGAT2-congenital disorder of glycosylation can include severe global developmental delays and profound intellectual disabilities. Individuals may also experience seizures and a bleeding tendency due to diminished platelet aggregation. Regular monitoring for these complications is important to manage symptoms effectively.

Question 9

How does MGAT2-congenital disorder of glycosylation affect daily life?

Accepted Answer

Daily life for individuals with MGAT2-congenital disorder of glycosylation can be challenging due to significant developmental and cognitive delays. Supportive care and tailored interventions are essential to help with daily activities and learning. Families often work closely with healthcare teams to create a supportive environment that meets the individual's needs.

Question 10

What is the prognosis for someone with MGAT2-congenital disorder of glycosylation?

Accepted Answer

The prognosis for individuals with MGAT2-congenital disorder of glycosylation varies widely based on the severity of symptoms and access to specialized care. Many individuals face lifelong challenges, particularly with cognitive and developmental functions. However, with improved standards of care and ongoing support, some outcomes have shown positive developments over time.

Question 11

Are there any specific specialists recommended for MGAT2-congenital disorder of glycosylation?

Accepted Answer

Families dealing with MGAT2-congenital disorder of glycosylation are encouraged to connect with a multidisciplinary team of specialists. This may include genetic counselors, neurologists, and developmental pediatricians who can provide comprehensive care and support. Regular follow-ups with these specialists can help manage symptoms and monitor for any complications.

Organ System	Phenotype Count	Example Features
Brain and nerves	5	Seizure, Aggressive behavior, Severe intellectual disability
Head and neck	4	Microcephaly, Macrocephaly, Everted lower lip vermilion
Growth and development	3	Short stature, Postnatal growth retardation, Failure to thrive
Bones and joints	3	Mild bone density loss (osteopenia), Thoracolumbar kyphoscoliosis, Slender long bone
Muscles	1	Generalized hypotonia
Ears	1	Inner ear hearing loss (sensorineural hearing impairment)
Heart and blood vessels	1	Ventricular septal defect
Arms and legs	1	Stereotypical hand wringing

Research Type	Count	% of Total
Research summaries	74	44%
Laboratory research	72	43%
Testing and diagnosis research	10	6%
Disease patterns and progression	5	3%
Patient case studies	4	2%
Other research	1	1%
New treatment approaches	1	1%

Kisho

MGAT2-congenital disorder of glycosylation

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

MGAT2-congenital disorder of glycosylation

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is MGAT2-congenital disorder of glycosylation?

What are the symptoms of MGAT2-congenital disorder of glycosylation?

What causes MGAT2-congenital disorder of glycosylation?

How is MGAT2-congenital disorder of glycosylation inherited?

How rare is MGAT2-congenital disorder of glycosylation?

How is MGAT2-congenital disorder of glycosylation diagnosed?

Are there treatments for MGAT2-congenital disorder of glycosylation?

What complications can arise from MGAT2-congenital disorder of glycosylation?

How does MGAT2-congenital disorder of glycosylation affect daily life?

What is the prognosis for someone with MGAT2-congenital disorder of glycosylation?

Are there any specific specialists recommended for MGAT2-congenital disorder of glycosylation?